BofA Securities downgrades Dassault Aviation amid margin, EPS concerns

BofA Securities downgraded Dassault Aviation to "underperform" from "neutral," cutting its price target to €290 from €310, citing expected weaker margins from new business jet deliveries and limited exposure to broader European defense spending. Analysts lowered 2025-28 EBIT forecasts by 10-19% due to the learning curve on Falcon 6X/10X programs and uncertainty surrounding the Future Combat Air System (FCAS), projecting negative free cash flow from 2026 if no new Rafale orders materialize, despite a recent stock rally.

Analysis

BofA Securities has downgraded Dassault Aviation to “underperform” from “neutral” and cut its price objective to €290, signaling significant headwinds. The downgrade is rooted in expectations of weaker margins, with analysts cutting 2025-28 EBIT forecasts by 10-19%, which now stand 7-18% below consensus. This margin pressure stems from the production ramp-up of the new Falcon 6X and 10X business jets, whose associated learning curve is expected to weigh on profitability through 2030—a near-term drag acknowledged by CEO Eric Trappier. Compounding this issue is the company's limited exposure to the broader European rearmament trend, as approximately 65% of its revenue is from defense sales heavily reliant on France. Furthermore, the Future Combat Air System (FCAS) program faces uncertainty due to political friction, creating a potential "overhang for the investment case." The financial outlook reflects these challenges, with a projected 9.9% decline in adjusted EPS for 2025 and a critical swing to negative free cash flow in 2026 (-€465 million) and 2027 (-€831 million) as pre-delivery payments for Rafale exports conclude. Analysts warn this cash strain could worsen if no new Rafale orders are secured within 12-18 months, justifying the stock's valuation discount despite its 49% year-to-date gain.

Key Decisions for Investors

• Investors should reassess bullish positions, as the BofA analysis suggests consensus estimates for margin expansion may be overly optimistic given the production learning curve for new business jets and below-consensus EBIT forecasts.
• Monitor key catalysts closely, particularly the announcement of new Rafale export orders within the next 12-18 months, as their absence would validate concerns over a significant negative free cash flow trajectory.
• Consider the company's relative positioning; despite its year-to-date gains, the stock has significantly underperformed the European defense sector, and its limited exposure to pan-European rearmament and FCAS program uncertainty may warrant rotating capital to peers with more favorable tailwinds.